Apo E variants in patients with type III hyperlipoproteinemia (Q28236370)

ORCID Public Data File 2021

author name string

F Civeira

1

0 references

M Pocoví

2

0 references

A Cenarro

3

0 references

E Casao

4

0 references

E Vilella

5

0 references

J Joven

6

0 references

J González

7

0 references

A L Garcia-Otín

8

0 references

J M Ordovás

Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E

9

0 references

language of work or name

English

0 references

publication date

20 December 1996

0 references

published in

Atherosclerosis

0 references

volume

127

0 references

issue

2

0 references

page(s)

273-82

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Apolipoprotein E polymorphism and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Apolipoprotein E polymorphism and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Impact of apolipoprotein E genotype variation on means, variances, and correlations of plasma lipid, lipoprotein, and apolipoprotein traits in octogenarians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Apolipoprotein E polymorphism in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide probes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Genotyping compared with protein phenotyping of the common apolipoprotein E polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Lipoproteins in familial dysbetalipoproteinemia. Variation of serum cholesterol level associated with VLDL concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136 → Ser) variant in multigenerational pedigree studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Identification of a new apolipoprotein E variant (E2 Arg142-->Leu) in type III hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2

Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905969-2